Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...

The US Department of Health and Human Services (HHS) has terminated 22 messenger RNA vaccine research projects, totalling ...

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...

Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA ...

The Trump administration says it is pulling half a billion dollars from U.S. government-funded research projects to create ...

The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects ...

BioNTech has agreed to pay UK drugmaker GSK royalties on its Covid-19 and influenza vaccines as part of a patent settlement with CureVac, in a deal that allows the biotech to move forward with the ...

Despite 22 active research projects aimed at advancing mRNA vaccines against various diseases, Kennedy claims the technology ...